RTW INVESTMENTS, LP - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 118 filers reported holding RELMADA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.

Quarter-by-quarter ownership
RTW INVESTMENTS, LP ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$6,395,505
+22.0%
2,131,8350.0%0.14%
+35.0%
Q2 2023$5,244,314
+8.8%
2,131,8350.0%0.10%0.0%
Q1 2023$4,817,947
-33.2%
2,131,835
+3.1%
0.10%
-32.0%
Q4 2022$7,216,706
-92.6%
2,067,824
-21.8%
0.15%
-93.5%
Q3 2022$97,898,000
+95.5%
2,644,475
+0.3%
2.26%
+74.4%
Q2 2022$50,088,000
-26.9%
2,637,581
+3.8%
1.29%
-8.8%
Q1 2022$68,557,000
+39.2%
2,540,074
+16.2%
1.42%
+97.4%
Q4 2021$49,258,000
+22.2%
2,186,324
+42.2%
0.72%
+18.3%
Q3 2021$40,312,000
-18.1%
1,538,0260.0%0.61%
-18.2%
Q2 2021$49,232,000
-8.7%
1,538,026
+0.5%
0.74%
-11.7%
Q1 2021$53,897,000
+11.1%
1,530,717
+1.2%
0.84%
+3.3%
Q4 2020$48,511,000
-14.7%
1,512,673
+0.1%
0.81%
-40.5%
Q3 2020$56,857,000
-14.2%
1,511,337
+2.1%
1.37%
-26.6%
Q2 2020$66,268,000
+97.3%
1,480,852
+50.4%
1.86%
+28.9%
Q1 2020$33,583,000
+29.6%
984,542
+48.2%
1.45%
+47.9%
Q4 2019$25,915,000664,4840.98%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
VR Adviser, LLC 2,270,072$61,269,0009.93%
GREAT POINT PARTNERS LLC 790,000$21,322,0005.15%
ACUTA CAPITAL PARTNERS, LLC 342,000$9,231,0004.31%
COWEN AND COMPANY, LLC 1,164,361$31,426,0003.02%
Altium Capital Management LP 206,000$5,560,0001.86%
BVF INC/IL 1,647,400$44,463,0001.78%
RTW INVESTMENTS, LP 2,540,074$68,557,0001.42%
Vivo Capital, LLC 705,882$19,052,0001.31%
RA Capital Management 2,000,000$53,980,0001.18%
SPHERA FUNDS MANAGEMENT LTD. 291,252$7,861,0001.11%
View complete list of RELMADA THERAPEUTICS INC shareholders